Patent ID: 11858922
Assignee: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 28:
29. A method of diagnosing a disease, disorder or condition in a mammal including the step of administering the compound of claim 3, or the pharmaceutically acceptable salt or solvate thereof, which compound, pharmaceutically acceptable salt or solvate is labelled, to the mammal or to a biological sample obtained from the mammal to facilitate diagnosis of the disease, disorder or condition in the mammal, wherein the disease, disorder or condition is responsive to inhibition of activation of the NLRP3 inflammasome.